The data from this study confirm the report of Adlersberg and associates 5 that age and sex account for a significant proportion of the variance in serum cholesterol level. Our data do not support the findings of Lang and Haits 1 that serum cholesterol level is higher among either young or old patients with major depression than among age-and sex-matched normal controls. Thus, an abnormally high serum cholesterol level is not selective for major depression and there fore is not a useful biological marker for major de pression.
A moxapine is a relatively new tricyclic antidepres sant with a chemical structure which is chemically distinct from that of other tricyclic antidepressants 1. Agranulocytosis is a relatively rare, but potentially lethal, side effect of tricyclic antidepressants 2. In this report I present a case of agranulocytosis that devel oped in a woman who had been treated with amoxa pine for 10 weeks. I am unaware of any previous reports of agranulocytosis associated with amoxapine.
CASE REPORT
Ms. A, a 42-year-old woman, was treated with amoxa pine, 50 mg/day, for severe panic disorder complicated by depressive symptoms. On day 32 of amoxapinc therapy, she was hospitalized on the psychiatric unit of a community hospital because of intensification of her symptoms of panic.
She remained there for 2 weeks, and her dose of amoxapine was increased to 150 mg/day. She was taking no other medications. The results of her physical examination were normal. Her WBC count was 4,200/mm3 with 57% neutro phils, 27% lymphocytes, 6% rnonocytcs, 5% eosinophiis, and 5% band cells. Her psychiatric condition stabilized and she was discharged from the hospital. On day 65 of amoxa pine therapy, Ms. A contacted her physician because of malaise, weakness, fever, and chills that had persisted for 3 days. Her WBC count was 200/mm3 with 0% neutrophils, 92% lymphocytes, and 8% monocytes. Amoxapine therapy was discontinued. A stormy 47-day hospitalization ensued, with a lengthy stay in the intensive care unit. Her agranulo cytosis was complicated by staphylococcal septicemia, possi ble endocarditis, pleural effusion, empyema, arterial embo lism, exfoliative dermatitis, and acute respiratory distress syndrome. Bone marrow aspiration showed hypocellular bone marrow with marked myeloid suppression. Treatment included leukocyte transfusions, ventilatory support, paren teral antibiotics, and anticoagulation therapy. On day 82, her WEC count was 11,300/mm3 with 15% bands and 71% neutrophils. Ms. A was discharged on day 114. Her condi tion has been stable since then, with normal complete blood counts.
DISCUSSION
This case demonstrates an association between amoxapine and agranulocytosis. The risk of potential ly fatal toxic bone marrow suppression should be considered in the prescription of most psychotropic medications. The period of maximum risk of druginduced agranulocytosis is reported to be at about weeks 3-4, but the risk continues to at least weeks 8-12 3. In this case, agranulocytosis occurred after 10 weeks of amoxapine therapy. Our enthusiasm for using the newer antidepressants that are being market ed in this country as safe products 4 should be tempered by an awareness of the risks associated with them. threshold levels of electrical energy, and oxygenation during ECT. The present study reports the occurrence of delirium in a patient who received only four bilater al sinusoidal treatments. Delirium did not redevelop after subsequent administration of unilateral briefpulse ECT.
CASE REPORT E CT, when administered 2-3 times a week, seldom produces a severe organic brain syndrome 1, 2. It has been suggested 2 that the incidence of this complication can be reduced by the use of unilateral electrode placements, threshold rather than supra Mr. A was a 57-year-old man with a bright-normal to superior Shipley IQ. He had an 18-year history of intermit tent depression, which had begun soon after the accidental drowning of a son. Four months before Mr. A's admission to our hospital, his father had died, after which he became psychotically depressed, with vegetative?signs and symp toms; mood-congruent delusions; suicidal, homicidal, and persecutory ideation; and auditory hatlucinations. Before transfer to our hospital, Mr. A was hospitalized and treated with maprotiline 125 mg/day, desipramine 75 mg/day, and trifluoperazine S mg/day without therapeutic response.
A physical examination of Mr. A after transfer was normal except for left-sided ptosis, increased muscle tone with mild cogwheeling, mild gait disturbance, and a positive snout reflex. An EEG was slightly abnormal, with some intermit tent irregular slowing in the left midtemporal and anterior temporal regions. A heat stroke 9 months before the current hospitalization was thought to be secondary to neuroleptic treatment. Two months later, Mr. A developed a persistent hypesthesia of the left hand. Neurologic evaluation for possible cerebrovascular disease including a CAT scan was negative. Pre-ECT spine X-rays revealed a widespread varie ty of degenerative changes in the spinal column, some severe. He also had had spinal decompression surgery.
After Mr. A gave informed consent for ECT, he was randomly assigned to receive bilateral sinusoidal ECTas part of an ongoing research investigation. Medication for agita tion oral thioridazine, 50 mg as needed was discontinued 3 days before lIT. ECT was administered on Mondays, Wednesdays, and Fridays and was modified by atropine, .6-1.2 mg subcutaneously 30 minutes before treatment; metho hexital, 60 mg i.v.; succinylcholine, 60-90 mg i.v.; curare, 3-4.5 mg i.v.; and 100% oxygen. The small dose of curare was needed to aid in the achievement of total relaxation because of the patient's vertebral disease. Electrical stimula tion consisted of a bidirectional sinusoidal stimulus 140 V, 60 Hz, .S-.6-second duration, mean stimulus energy of 56 J, and mean seizure duration of 73 seconds. Seizure duration was measured electroencephalographically.
By the fourth treatment, Mr. A had become profoundly confused and dysnomic. Neuropsychological testing 2 days after the fourth ECT see table 1 resulted in a low level of performance on a variety of tests 3. Neurological examina tion at this time revealed no other change from the baseline evaluation. CAT scan with enhancement revealed no abnor malities, but an EEG performed 8 days after the fourth ECT showed a mild to moderate diffuse slowing of background rhythms, with an accentuation in the left temporal region of greater degree than that seen before ECT. We concluded that ECT had induced an unusually severe and prolonged acute confusional state OSM-Ill delirium. Repeat neuropsy chological testing 6 days after the fourth ECT corroborated this conclusion, in that most cognitive functions were im proving 4. Because Mr. A had shown a partial therapeutic response to ECT, we decided to continue with a less "toxic" form of ECT, namely, unilateral nondominant brief-pulse ECT. However, he was left-handed, showed other signs of mixed cerebral dominance according to d'Elia's criteria 5, and had a family history of sinistrality. Consequently, cerebral domi nance was determined by a sequence of brief-pulse bilateral, right, and then left unilateral treatments one of each as described by Clyma 6 . This trial was initiated 12 days after the last sine wave bilateral treatment. Mr. A's verbal respons es were delayed longer after left than after right unilateral ECT. It was therefore concluded that his left cerebral hemi sphere subserved language functions. He was then given three more right unilateral brief-pulse treatments. All briefpulse treatments used a bidirectional electrical stimulus 800-mA peak amplitude, 60 pulse-pairs/second, .75-msec pulse width, 1.00-1.25-second duration, mean stimulus energy of 16 J, and mean seizure duration of 79 seconds. A good therapeutic response was attained.
Mr. A was retested 2 and 6 days after his 10th last treatment see table 1. The test results indicate that cogni tion was still improving despite the interpolated unilateral pulse treatments. This improvement is significant because there usually is some cumulative buildup of confusion during a treatment course, even with unilateral nondominant ECT 7. A repeat EEG performed 8 days after the last ECT revealed very mild generalized slowing, at times with left temporal predominance, but both findings were present to a lesser degree than after the smaller number of bilateral sine wave treatments.
The etiology of this ECT-induced delirium is un clear. The presence of focal neurologic signs and preexisting focal EEG abnormalities suggests the possi bility of a focal CNS lesion that Was not evident radiographically, although these findings were incon sistent with each other on the basis of laterality.
The present case indicates that delirium after stan dard bilateral sinusoidal ECT does not necessitate the discontinuation of ECT 2, since delirium did not redevelop after subsequent administration of unilateral nondominant brief-pulse ECT. This result is consistent with the lesser degree of memory and EEG abnormali ties known 8 to occur with the use of unilateral nondominant brief-pulse ECT in patients without CNS abnormalities.
Less neuropsychological impairment in Mr. A after unilateral brief-pulse ECT than after bilateral sinusoi dal ECT may have been related to any of the following factors: 1 less electrical stimulation of the dominant cerebral hemisphere and the possible site of a preexist ing CNS lesion with unilateral ECT, 2 less electrical energy with the use of brief-pulse ECT, 3 less seizure generalization with unilateral brief-pulse ECT, or 4 natural resolution of the delirium unaffected by subse quent ECT administration 2, 4.
In addition to improved neuropsychological func tioning, Mr. A's affect continued to improve. Some investigators 9 report that unilateral brief-pulse ECT is not always as effective as bilateral sinusoidal ECT in treating depression, whereas other investigators 10 report similar antidepressive efficacy. In any event, the decrease in neuropsychological and depressive pathol ogy in the present case argues for using unilateral nondominant brief-pulse ECT in situations where a severe organic brain syndrome has occurred with G illes de Ia Tourette's syndrome is an illness that usually develops between age 2 and age 15 1 and DSM-tll. Isolated reports of later onset have involved incorrect diagnoses or have not been regarded as typical cases of the syndrome 2. A male patient is described here who met all the diagnostic criteria of DSM-III and Shapiro and associates 1 for the syn drome except that he developed symptoms after the age of 35. The other symptoms for Tourette's syn drome are the following: presence of recurrent, invol untary repetitive, rapid, purposeless motor movements affecting multiple muscle groups; multiple vocal tics; ability to suppress movements voluntarily for minutes to hours; variations in the intensity of the symptoms over weeks or months; and duration of symptoms for more than 1 year. CASE REPORT -Mr. A, age 45 years, has been treated at our institution for 3 years. He first complained of "strange sensations" in his stomach muscles and jaw at age 35. One year later lie observed a "restlessness" in his stomach muscles, arms, legs, and jaw and commented, "It was as if my muscles developed a life of their own." At age 40 he felt the urge to utter the word "shit" and subsequently uttered the word louder and standard ECT techniques or when the patient is felt rp be at increased risk for this to occur.
